Impact Biomedical (IBO) Goodwill (2022 - 2024)

Impact Biomedical (IBO) has reported Goodwill for 3 consecutive years, with -$25.1 million the latest figure, recorded in Q4 2024.

• For the quarter ending Q4 2024, Goodwill fell 200.0% year-over-year to -$25.1 million; the trailing twelve-month figure through Dec 2024 stood at -$25.1 million (down 200.0% YoY), and the FY2024 full-year result was -$25.1 million, down 200.0% from the prior year.
• Goodwill retreated to -$25.1 million in Q4 2024 per IBO's latest filing, from $25.1 million in the prior quarter.
• Across five years, Goodwill topped out at $46.4 million in Q3 2023 and bottomed at -$25.1 million in Q4 2024.
• Historically, Goodwill has averaged $21.5 million across 3 years, with a median of $25.1 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Goodwill changed 0.0% in 2023, then slumped 200.0% in 2024.
• Over 3 years, Goodwill stood at $25.1 million in 2022, then changed by 0.0% to $25.1 million in 2023, then plunged by 200.0% to -$25.1 million in 2024.
• According to Business Quant data, Goodwill over the past three periods registered -$25.1 million, $25.1 million, and $25.1 million for Q4 2024, Q3 2024, and Q2 2024 respectively.